Page 107 - EJMO-9-2

Eurasian Journal of Medicine

and Oncology

ORIGINAL RESEARCH ARTICLE
Outcomes of ultrasound-guided

vacuum-assisted excision of breast lesions: A
single-center study

Khalid M. Alshamrani 1,2,3 * , Samar Alshehri 2,3,4 , Nesreen Abourokbah 2,3,4 , and
Shaza Alsharif 1,2,3
1 College of Applied Medical Sciences, King Saud bin Abdulaziz University for Health Sciences,
Jeddah, Saudi Arabia
2 King Abdullah International Medical Research Center, Jeddah, Saudi Arabia
3 Ministry of the National Guard - Health Affairs, Jeddah, Saudi Arabia
4 College of Medicine, King Saud bin Abdulaziz University for Health Sciences, Jeddah, Saudi Arabia

Abstract
This study aims to present ultrasound-guided vacuum-assisted excision (UGVAE) as
an alternative therapeutic approach for benign breast lesions. In addition, it evaluates
the procedure’s performance, associated complications, and clinical outcomes. This
single-center, retrospective cohort study, approved by the Institutional Review Board,
included 67 female patients who underwent UGVAE for breast lesions using 7 – 10 G
*Corresponding author: needles. The study analyzed various parameters, including patient demographics,
Khalid M. Alshamrani imaging features, and follow-up findings. Indications for UGVAE included patient
(alshamranik@ksau-hs.edu.sa) preference, pain, palpable lump, nipple discharge, discordant biopsy results, and
Citation: Alshamrani KM, interval increase in breast imaging-reporting and data system (BI-RADS) 3 lesions.
Alshehri S, Abourokbah N, Lesion size, shape, echogenicity, and location were assessed through ultrasound
Alsharif S. Outcomes of
ultrasound-guided vacuum-assisted and mammography. UGVAE was performed by two experienced radiologists, and
excision of breast lesions: A single- post-procedure complications were documented. Data were analyzed using the
center study. Eurasian J Med Oncol. Statistical Package for the Social Sciences and descriptive statistical methods.
2025;9(2):99-108.
doi: 10.36922/ejmo.8436 The mean age of the study population was 41.8 ± 14 years, and the mean lesion
size was 1.7 ± 0.85 cm. A previous biopsy of the lesion was recorded in 19.4% of
Received: January 7, 2025 cases, and 7.5% of the patients had a history of breast cancer. The indications for
Revised: February 11, 2025 UGVAE included patient preference (22.4%), pain (16.4%), palpable lump (14.9%),
Accepted: March 7, 2025 and an interval increase in BI-RADS 3 lesions (17.9%). Abnormal mammographic
findings were reported in 95.1% of cases. Sonographic features predominantly
Published online: March 19, 2025 included circumscribed (94%) and oval (73.1%) lesions. Complete excision was
Copyright: © 2025 Author(s). achieved in 80.6% of cases, and hematoma occurred in 13.4% of patients as a post-
This is an Open-Access article procedure complication. Histopathological results confirmed all lesions as benign,
distributed under the terms of the
Creative Commons Attribution with fibroadenoma being the most common diagnosis (50.7%). Follow-up imaging
License, permitting distribution, showed no significant residual lesion in 46.3% of patients. UGVAE is considered a
and reproduction in any medium, cost-effective, minimally invasive, and safe alternative to surgical excision for benign
provided the original work is
properly cited. breast lesions.
Publisher’s Note: AccScience
Publishing remains neutral with Keywords: Vacuum-assisted; Ultrasound; Benign breast lesions; Breast mass;
regard to jurisdictional claims in
published maps and institutional Breast biopsy
affiliations.

Volume 9 Issue 2 (2025) 99 doi: 10.36922/ejmo.8436